Drugs approved by the FDA in 2020 reflect continuing trend of structural innovation

by CAS, a division of the American Chemical Society

New drug innovation remained strong in 2020. The total of 53 drugs approved represented the second-highest number of approvals in more than two decades, a positive indicator of productivity in the pha...

Read more

The Gregory Foundation For Cancer Research Strengthens Their Commitment By Investing Again In Oncoheroes Biosciences

by Oncoheroes Biosciences

“Although Gregory received cutting edge immunotherapies and targeted therapies, including CAR-T 19 and an allogeneic CAR-T, the disease was very aggressive, and he succumbed to cancer,” explained ...

Read more

Avoiding Costly IP Missteps: Insights for high-quality due diligence searches

by CAS, a division of the American Chemical Society

As chemical and life science companies seeking to monetize their IP portfolios emerge from the challenges of COVID-19, 2021 looks to be a year that will see increased product licensing, acquisitions a...

Read more

Challenges in manufacturing high value lyophilized oncology drugs

by Telstar

A complete integrated freeze-drying system designed for high value anticancer products consisting of a reduced foot-print freeze dryer with an innovative loading/unloading system, integrating a steam-...

Read more

OncoDNA announces expansion of its services into the United States

by OncoDNA

The theranostic and genomic company signs subcontract service agreement with HalioDx’s CLIA-certified laboratory in Richmond, Virginia

Read more

ORYZON Reports Results for Quarter Ended September 30, 2020 and Provides Corporate Update

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported ...

Read more

American Hospital of Paris and OncoDNA Partner to Advance Breast Cancer Patients Management

by OncoDNA

American Hospital of Paris and OncoDNA announced a new joint initiative that is intended to advance the use of precision medicine in routine clinical practice for patients with metastatic breast cance...

Read more

EuCanImage: Next-generation artificial intelligence in oncology

by Fundació Bosch i Gimpera

EuCanImage has been launched. This project from the Horizon 2020 program is coordinated by Karim Lekadir, Ramón y Cajal postdoctoral researcher at the Faculty of Mathematics and Computer Science of t...

Read more

Maximizing the oncology production process

by Telstar

Telstar’s cutting-edge technologies and integrated process equipment & systems covering all the critical phases of the oncology production are designed according to the higher requirements of qualit...

Read more

ONCODNA provides an update about the friendly takeover bid on INTEGRAGEN

by OncoDNA

OncoDNA SA has become the first shareholder of IntegraGen SA (Paris: ALINT), holding 29.99% of the existing shares, as result of purchases of shares on the Euronext Growth market .

Read more

Agreement to file a friendly takeover bid initiated by OncoDNA on IntegraGen to acquire all outstanding shares at a price of 2.20€ per share

by OncoDNA

This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both c...

Read more

Boehringer acquires Northern Biologics preclinical oncology pipeline

by CataloniaBio

Boehringer Ingelhe​im has acquired two preclinical antibodies from Canadian firm Nor​thern Biologics with the aim of further strengthening its global position in cancer immunology.

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

La impronta inmunológica condiciona la ...

by Hospital Universitari de Bellvitge

Un estudio del Hospital de Bellvitge, el IDIBELL y la Icahn School of ...

Photos Stream